Kalpataru Power Transmission rose 3.1% to Rs 402.9 after the company said it secured new orders / notification of award of Rs 1,554 crore across various businesses.The company in a regulatory filing during market hours today announced that it bagged orders from India, CIS and Latin America in the power transmission business. Kalpataru Power Transmission s international subsidiary also secured new power transmission projects in Europe.
Commenting on the new order announcements, Manish Mohnot, MD & CEO of the company said, We are delighted with the new order wins in our power transmission business. These new order wins help us to strengthen our power transmission order book in India and overseas market. Our current year order inflow has reached around Rs 8,000 crore and additionally we have good visibility across all our businesses. Our order book visibility with low debt gives us confidence of growth from long-term perspective.
Read more about Utilties shares gain on Business Standard. Utilties stocks were trading in the positive zone, with the S&P BSE Utilities index rising 44.77 points or 2.08% at 2198.24 at 09:48 IST.
At meeting held on 01 March 2021The Board of Birla Corporation at its meeting held on 01 March 2021 has appointed Arvind Pathak (DIN: 00585588) as an Additional Director and
simultaneously the Managing Director & Chief Executive Officer of the Company for a
period of 3 (three) years w.e.f. 31 March 2021
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views an
Read more about Utilties stocks gain on Business Standard. Utilties stocks were trading in green, with the S&P BSE Utilities index increasing 36.74 points or 1.74% at 2148.48 at 09:48 IST.
Cadila Healthcare rose 1.12% to Rs 438.75 after the pharmaceutical company said that its US subsidiary has acquired experimental drug from Cyprium for treating Menkes disease.
Cyprium Therapeutics, a partner of Fortress Biotech, and Sentynl Therapeutics, a U.S.- based specialty pharmaceutical company owned by the Zydus Group, has announced its execution of an asset purchase agreement to commit development funding for and acquire Cyprium s proprietary rights to CUTX-101, its Copper Histidinate product candidate for the treatment of Menkes disease.
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of copper transporter ATP7A. CUTX-101 is in clinical development to treat patients with Menkes disease.